If chronic pain and systemic inflammation lead to AD pathology, than we predict that individuals with both chronic pain and elevated hs-CRP would show lower plasma Aβ42 and Aβ42/Aβ40 and higher total tau (t-tau) and NfL levels, consistent with higher AD risk (17). This evidence concerns the gene MAPT and Alzheimer disease.